ESLICARBAZEPINE ACETATE

Generic: ESLICARBAZEPINE ACETATE

Aurobindo Pharma LimitedManufacturer
ORALRoute
ESLICARBAZEPINE ACETATEActive Substance
2026-08-05Original Approval

ESLICARBAZEPINE ACETATE is FDA application ANDA216481, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
143 reports
2
SEIZURE
120 reports
3
OFF LABEL USE
108 reports
4
CONDITION AGGRAVATED
56 reports
5
HYPONATRAEMIA
52 reports
6
DIZZINESS
49 reports
7
SOMNOLENCE
48 reports
8
PRODUCT USE IN UNAPPROVED INDICATION
45 reports
9
UNDERDOSE
41 reports
10
GENERALISED TONIC-CLONIC SEIZURE
34 reports